DK0871467T3 - Ny formulering til afgivelse af peptid - Google Patents
Ny formulering til afgivelse af peptidInfo
- Publication number
- DK0871467T3 DK0871467T3 DK96917292T DK96917292T DK0871467T3 DK 0871467 T3 DK0871467 T3 DK 0871467T3 DK 96917292 T DK96917292 T DK 96917292T DK 96917292 T DK96917292 T DK 96917292T DK 0871467 T3 DK0871467 T3 DK 0871467T3
- Authority
- DK
- Denmark
- Prior art keywords
- formulation
- peptide
- delivery
- new formulation
- deslorelin
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPN3667A AUPN366795A0 (en) | 1995-06-20 | 1995-06-20 | Formulation for preventing reproductive function |
PCT/AU1996/000370 WO1997000693A1 (en) | 1995-06-20 | 1996-06-20 | Novel formulation for peptide release |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0871467T3 true DK0871467T3 (da) | 2002-12-23 |
Family
ID=3788008
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96917292T DK0871467T3 (da) | 1995-06-20 | 1996-06-20 | Ny formulering til afgivelse af peptid |
Country Status (17)
Country | Link |
---|---|
US (2) | US5925619A (ja) |
EP (1) | EP0871467B1 (ja) |
JP (1) | JP4016133B2 (ja) |
CN (1) | CN1145496C (ja) |
AT (1) | ATE223726T1 (ja) |
AU (2) | AUPN366795A0 (ja) |
CA (1) | CA2225796C (ja) |
DE (2) | DE122008000004I2 (ja) |
DK (1) | DK0871467T3 (ja) |
ES (1) | ES2182983T3 (ja) |
FR (1) | FR08C0001I2 (ja) |
HK (1) | HK1014874A1 (ja) |
NL (1) | NL300330I2 (ja) |
NZ (1) | NZ309697A (ja) |
PT (1) | PT871467E (ja) |
SI (1) | SI0871467T1 (ja) |
WO (1) | WO1997000693A1 (ja) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN366795A0 (en) * | 1995-06-20 | 1995-07-13 | Peptide Technology Limited | Formulation for preventing reproductive function |
ATE359805T1 (de) * | 1996-08-30 | 2007-05-15 | Peptech Ltd | Formulierung zur verzögerten freisetzung von peptidagonisten und -analoga des gnrh |
US8052982B2 (en) * | 1998-07-20 | 2011-11-08 | Peptech Animal Health Pty Limited | Bioimplant formulation comprising lecithin and stearin |
US6913761B1 (en) * | 1998-07-20 | 2005-07-05 | Peptech Limited | Bioimplant formulation |
US6211221B1 (en) * | 1999-04-05 | 2001-04-03 | Johnny W. Peterson | Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor |
BR0115067A (pt) * | 2000-10-30 | 2004-04-06 | Univ Zuerich | Análogos de gnrh para tratamento de incontinência urinária |
GB0221539D0 (en) * | 2002-09-17 | 2002-10-23 | Medical Res Council | Methods of treatment |
EP1711159B1 (en) * | 2003-12-30 | 2013-03-20 | Durect Corporation | Solid implants containing a block copolymer for controlled release of a gnrh compound |
EP1835885A1 (en) * | 2004-12-23 | 2007-09-26 | Durect Corporation | Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of a gnrh |
EP2205265A1 (en) * | 2007-09-11 | 2010-07-14 | Mondobiotech Laboratories AG | Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
DE102008015104A1 (de) | 2008-03-19 | 2009-09-24 | Basf Coatings Ag | Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS563846B2 (ja) * | 1972-10-12 | 1981-01-27 | ||
US4218439A (en) * | 1977-07-14 | 1980-08-19 | The Salk Institute For Biological Studies | Peptide which inhibits gonadal function |
US4256737A (en) * | 1979-06-11 | 1981-03-17 | Syntex (U.S.A.) Inc. | Long acting depot injectable formulations for LH-RH analogues |
CA1257199A (en) * | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
EP0257368B1 (en) * | 1986-08-11 | 1992-03-25 | American Cyanamid Company | Compositions for parenteral administration and their use |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US5538739A (en) * | 1989-07-07 | 1996-07-23 | Sandoz Ltd. | Sustained release formulations of water soluble peptides |
US5211952A (en) * | 1991-04-12 | 1993-05-18 | University Of Southern California | Contraceptive methods and formulations for use therein |
US5470582A (en) * | 1992-02-07 | 1995-11-28 | Syntex (U.S.A.) Inc. | Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles |
AUPN366795A0 (en) * | 1995-06-20 | 1995-07-13 | Peptide Technology Limited | Formulation for preventing reproductive function |
-
1995
- 1995-06-20 AU AUPN3667A patent/AUPN366795A0/en not_active Abandoned
-
1996
- 1996-06-20 AU AU59927/96A patent/AU701837B2/en not_active Expired
- 1996-06-20 US US08/981,285 patent/US5925619A/en not_active Expired - Lifetime
- 1996-06-20 ES ES96917292T patent/ES2182983T3/es not_active Expired - Lifetime
- 1996-06-20 DE DE122008000004C patent/DE122008000004I2/de active Active
- 1996-06-20 WO PCT/AU1996/000370 patent/WO1997000693A1/en active IP Right Grant
- 1996-06-20 PT PT96917292T patent/PT871467E/pt unknown
- 1996-06-20 JP JP50345797A patent/JP4016133B2/ja not_active Expired - Lifetime
- 1996-06-20 CA CA2225796A patent/CA2225796C/en not_active Expired - Lifetime
- 1996-06-20 CN CNB961948647A patent/CN1145496C/zh not_active Expired - Lifetime
- 1996-06-20 DK DK96917292T patent/DK0871467T3/da active
- 1996-06-20 NZ NZ309697A patent/NZ309697A/xx not_active IP Right Cessation
- 1996-06-20 EP EP96917292A patent/EP0871467B1/en not_active Expired - Lifetime
- 1996-06-20 DE DE69623652T patent/DE69623652T2/de not_active Expired - Lifetime
- 1996-06-20 SI SI9630524T patent/SI0871467T1/xx unknown
- 1996-06-20 AT AT96917292T patent/ATE223726T1/de active
-
1999
- 1999-01-08 HK HK99100086A patent/HK1014874A1/xx not_active IP Right Cessation
- 1999-02-17 US US09/251,411 patent/US6211152B1/en not_active Expired - Lifetime
-
2008
- 2008-01-08 NL NL300330C patent/NL300330I2/nl unknown
- 2008-01-10 FR FR08C0001C patent/FR08C0001I2/fr active Active
Also Published As
Publication number | Publication date |
---|---|
EP0871467A4 (en) | 2000-07-05 |
SI0871467T1 (en) | 2003-08-31 |
NL300330I1 (nl) | 2008-03-03 |
DE122008000004I2 (de) | 2009-08-06 |
CN1188414A (zh) | 1998-07-22 |
NL300330I2 (nl) | 2008-04-01 |
EP0871467A1 (en) | 1998-10-21 |
CA2225796C (en) | 2011-09-20 |
EP0871467B1 (en) | 2002-09-11 |
NZ309697A (en) | 1999-11-29 |
JP2001521482A (ja) | 2001-11-06 |
CN1145496C (zh) | 2004-04-14 |
DE69623652D1 (de) | 2002-10-17 |
DE122008000004I1 (de) | 2008-04-17 |
FR08C0001I2 (ja) | 2009-11-20 |
ES2182983T3 (es) | 2003-03-16 |
DE69623652T2 (de) | 2003-05-28 |
ATE223726T1 (de) | 2002-09-15 |
FR08C0001I1 (ja) | 2008-03-21 |
CA2225796A1 (en) | 1997-01-09 |
JP4016133B2 (ja) | 2007-12-05 |
PT871467E (pt) | 2002-12-31 |
AU701837B2 (en) | 1999-02-04 |
AUPN366795A0 (en) | 1995-07-13 |
AU5992796A (en) | 1997-01-22 |
US6211152B1 (en) | 2001-04-03 |
US5925619A (en) | 1999-07-20 |
HK1014874A1 (en) | 1999-10-08 |
WO1997000693A1 (en) | 1997-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR08C0001I2 (ja) | ||
DK0742714T3 (da) | Flydende farmaceutiske præparater omfattende thyroideahormoner | |
AU4718496A (en) | Use of aerogels in agriculture | |
NO931766L (no) | Topiske preparater for transdermal avlevering av forloeperlegemiddelderivater av morfin | |
FI962154A0 (fi) | Koostumus terapeuttisten tuotteiden in vivo valmistusta varten | |
ES2184895T3 (es) | Sistema no polimerico de administracion con liberacion retardada. | |
MY113488A (en) | Compounds with growth hormone releasing properties | |
DE69531741D1 (de) | Verbindungen und zusammensetzungen zur verabreichung aktiver stoffe | |
ATE387430T1 (de) | Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe | |
FI963696A (fi) | Geeli ihosairauksien hoitoon ja ihon desinfiointiin | |
BR9707637A (pt) | Sistema implantável implante destinado a administração subcutânea ou local e conjunto farmacêutico | |
EP1178988A4 (en) | THERAPEUTIC COMPOUNDS AND METHODS | |
HUP9602498A2 (hu) | Antimikrobiális hatású gyógyászati készítmények | |
UA35611C2 (uk) | Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри | |
HK1038310A1 (en) | Compositions and methods for treating intracellular infections. | |
OA09771A (en) | Asphodelus composition for increasing white blood cell count. | |
MX9803093A (es) | Suministro de polipeptidos biologicamente activos. | |
UA30723A (uk) | Спосіб лікування аутоімунних захворювань | |
MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. |